Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Over 1.5 million people worldwide die from lung cancer per year. The disease has an extremely poor prognosis and there has been no improvement in the 5-year survival rate in the last 30 years. Unfortunately currently available treatments do not prevent the relentless progression of the disease. There has been lack of optimism regarding treatment advances in the last ten years, and progress in treating or predicting the risk for lung cancer has been slow. Ongoing efforts to improve the survival of patients with lung cancer should be centered on achieving an earlier diagnosis in addition to developing new targeted or individualized therapies for the disease.
Lung Cancer: Future Challenges and Opportunities
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi